What are Theravance Biopharma's profit margins?

Theravance Biopharma (TBPH) runs a 60.8% gross margin and a 1.2% operating margin, with a 104.3% net margin.

Where do Theravance Biopharma's ratios come from?

Every ratio is computed from Theravance Biopharma's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Theravance Biopharma TBPH Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Operating margin	-3.4%+69.6pp	-72.9%+24.7pp	-97.6%+81.5pp	-179.1%+287pp
Net margin	98.5%+186pp	-87.6%+8.5pp	-96.1%-1,795pp	1,698.5%+2,059pp
Returns
Return on equity	44.8%+73.9pp	-29%-12.2pp	-16.9%—	——
Return on invested capital	-1.6%+21.2pp	-22.9%+3.9pp	-26.8%—	——
Efficiency
Asset turnover	0.3×+0.1×	0.2×+0.1×	0.1×0.0×	0.1×0.0×
Liquidity
Current ratio	10.9×+5.9×	5×-0.4×	5.4×-6.9×	12.3×+8.0×
Leverage
Debt-to-equity	0.1×-0.1×	0.3×+0.1×	0.2×+0.1×	0.1×—
Per Share
Book value per share	$5.76+60.3%	$3.59-6.7%	$3.85-35.8%	$6.00+223%
Valuation
Market capitalization	$890.32M+67.5%	$462.73M-16.7%	$555.42M-26.5%	$756.17M-9.1%
Price / earnings	7.8×—	——	——	0.9×—
Price / sales	8.1×0.0×	7.2×-2.5×	9.7×-5.1×	14.7×-0.3×
Price / book	3.1×-0.1×	2.6×0.0×	2.6×+0.9×	1.7×—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Theravance Biopharma.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Theravance Biopharma's profit margins?: Theravance Biopharma (TBPH) runs a 60.8% gross margin and a 1.2% operating margin, with a 104.3% net margin.
Where do Theravance Biopharma's ratios come from?: Every ratio is computed from Theravance Biopharma's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.